fluorodeoxyglucose f18 has been researched along with fluorouracil in 130 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.77) | 18.7374 |
| 1990's | 12 (9.23) | 18.2507 |
| 2000's | 42 (32.31) | 29.6817 |
| 2010's | 72 (55.38) | 24.3611 |
| 2020's | 3 (2.31) | 2.80 |
| Authors | Studies |
|---|---|
| Eremin, O; Evans, NT; Gvozdanovic, D; Heys, SD; Mallard, JR; Roeda, D; Smith, FW | 1 |
| Haberkorn, U; Schadel, A; Seifert, E; Strauss, LG | 1 |
| Strauss, LG | 1 |
| Austin, JR; Kim, EE; Wong, FC | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
| Haberkorn, U; Reisser, C; Strauss, LG | 1 |
| Cronin, B; Cunningham, D; Findlay, M; Flower, M; Hickish, T; Husband, J; Iveson, A; Ott, R; Pratt, B; Young, H | 1 |
| Bailey, D; Cunningham, V; Matthews, J; Price, P | 1 |
| Dimitrakopoulou-Strauss, A; Doll, J; Hohenberger, P; Irngartinger, G; Oberdorfer, F; Schlag, P; Strauss, LG; van Kaick, G | 1 |
| Dimitrakopoulou-Strauss, A; Gutzler, F; Moehler, M; Raeth, U; Strauss, LG; Stremmel, W | 1 |
| Baum, RP; Dietrich, C; Hör, G; Kirchner, J; Rink, T; Schröder, O; Zeuzem, S | 1 |
| Bangard, M; Bangard, N; Bender, H; Biersack, HJ; Metten, N; Mezger, J; Schomburg, A | 1 |
| Fujiwara, T; Fukuda, H; Gamo, M; Ido, T; Ishioka, C; Iwata, R; Kanamaru, R; Murakawa, Y; Yoshioka, T | 1 |
| Griffiths, JR; Judson, IR; Leach, MO; McSheehy, PM | 1 |
| Akhurst, T; Cohen, AM; Erdi, Y; Finn, RD; Gollub, MJ; Guillem, JG; Humm, J; Klimstra, DS; Larson, S; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Puig-La Calle, J; Ruo, L; Saltz, L; Tickoo, S; Yeung, H | 1 |
| Barbet, N; Buuren, IV; Capdeville, R; Choi, L; de Vries, EG; Dumez, H; Groen, HJ; Muskiet, F; Oosterom, AT; Paridaens, R; Seeghers, M; Uges, DR; van der Graaf, WT | 1 |
| Imamoto, E; Kondo, M; Kou, T; Kuchide, M; Kunishima, S; Naito, Y; Taniguchi, H; Tomatsuri, N; Yoshida, N; Yoshikawa, T | 1 |
| Choi, NC; Fischman, AJ; Lynch, TJ; Mathisen, DJ; Ryu, JS | 1 |
| Burcombe, RJ; Emmott, J; Lowe, J; Makris, A; Pittam, M; Wong, WL | 1 |
| Grüterich, G; Kovács, AF; Wagner, M | 1 |
| Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Dimitrakopoulou-Strauss, A; Rudi, J; Strauss, LG | 1 |
| Aboagye, EO; Barthel, H; Brady, F; Cleij, MC; Collingridge, DR; He, Q; Hutchinson, OC; Luthra, SK; Osman, S; Price, PM | 1 |
| Becker, K; Busch, R; Dittler, HJ; Fink, U; Link, T; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Stahl, A; Stein, H; Weber, WA | 1 |
| Alvarez, E; Arranz, JA; Calvo, FA; Carreras, JL; Desco, M; Domper, M; Martínez-Lázaro, R; Matute, R | 1 |
| Andoh, H; Asanuma, Y; Furuya, T; Hatazawa, J; Koyama, K; Sato, T; Shibata, S; Shimosegawa, E; Yamamoto, Y; Yoshioka, M | 1 |
| Arulampalam, TH; Costa, DC; Croasdale, I; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Visvikis, D | 1 |
| Akhurst, T; Guillem, JG; Klimstra, DS; Larson, S; Mazumdar, M; Minsky, BD; Moore, HG; Ruo, L; Saltz, L; Wong, WD | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Irngartinger, G; Rudi, J; Rühl, A; Strauss, LG; Stremmel, W | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Hicks, RJ; Leong, T; Lim-Joon, D; Loi, S; Mackay, J; Michael, M; Mitchell, P; Mukesh, B; Ngan, SY; Rischin, D; Zalcberg, J | 1 |
| Hirota, T; Kato, T; Nishimura, T; Tanaka, O; Yamagami, T | 1 |
| Akhurst, T; Blumgart, L; Burt, BM; Fong, Y; Jarnagin, W; Kates, TJ; Larson, SM; Mazumdar, M; Riedel, ER; Yeung, H | 1 |
| Gupta, C; Gupta, V; Malani, AK; Rangineni, S | 1 |
| Cheng, JD; Cohen, SJ; Eisenberg, D; Engstrom, P; Freedman, G; Haluszka, O; Hoffman, J; Konski, A; McGarrity, E; Meropol, NJ; Sigurdson, E; Watson, JC | 1 |
| Cho, SY; Engles, JM; Ishimori, T; Mambo, E; Quarless, SA; Wahl, RL | 1 |
| Corstens, FH; de Geus-Oei, LF; Leer, JW; Oyen, WJ; Punt, CJ; Ruers, TJ | 1 |
| Babsky, AM; Bansal, N; Hekmatyar, SK; Hutchins, GD; Zhang, H | 1 |
| Park, KG; Smith, TA; Suttie, SA | 1 |
| Collie-Duguid, ES; Schweiger, LF; Sharma, RI; Smith, TA; Wang, WG; Welch, AE | 1 |
| Bredenkamp, R; Hennig, M; Herrmann, K; Lordick, F; Lorenzen, S; Ott, K; Peschel, C; Schwaiger, M; Weber, WA; Wieder, H | 1 |
| Castellucci, P; Di Fabio, F; Fanti, S; Funaioli, C; Giaquinta, S; Longobardi, C; Martoni, AA; Mutri, V; Pinto, C; Rojas Llimpe, FL; Sperandi, F | 1 |
| Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T | 1 |
| Sharma, RI; Smith, TA | 1 |
| Haustermans, K; Lee, JA; Loeckx, D; Maes, F; Nuyts, J; Penninckx, F; Roels, S; Slagmolen, P; Stroobants, S | 1 |
| Balzarini, J; Berndsen, SC; Direcks, WG; Lammertsma, AA; Molthoff, CF; Peters, GJ; Proost, N; Spreeuwenberg, MD | 1 |
| Ameye, L; Delatte, P; Flamen, P; Ghanem, G; Hendlisz, A; Van Den Eynde, M; Vanderlinden, B | 1 |
| Cohen, SJ; Konski, A; Li, T; Meropol, NJ; Sigurdson, E; Small, W; Spies, S; Stryker, S; Wahl, A; Yu, JQ | 1 |
| Arens, A; Beets, GL; Beets-Tan, RG; Buijsen, J; de Ruysscher, D; Driessen, A; Kessels, AG; Lammering, G; Oellers, M; van Baardwijk, A; Vanhauten, B; Vliegen, RF | 1 |
| Anazawa, S; Eto, K; Ogawa, M; Takao, Y; Ushigome, T; Watanabe, M; Yamagata, T; Yanaga, K | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Hoffend, J; Koczan, D; Pan, L; Strauss, LG | 1 |
| Ectors, N; Haustermans, K; Lee, JA; Loeckx, D; Maes, F; Nuyts, J; Penninckx, F; Roels, S; Slagmolen, P; Stroobants, S; Vandecaveye, V | 1 |
| Banti, E; Bianchini, E; Capirci, C; Crepaldi, G; Del Favero, G; Facci, E; Galeotti, F; Gava, M; Marano, G; Panzavolta, R; Pasini, F; Rampin, L; Rubello, D | 1 |
| Jung, SY; Kang, HS; Kim, EA; Kim, SK; Kim, SW; Ko, KL; Kwon, Y; Lee, KS; Lee, S; Lee, SJ; Min, SY; Nam, BH; Park, C; Park, IH; Ro, J; Shin, KH | 1 |
| Choi, M; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Venkatramanamoorthy, R; Zalupski, MM | 1 |
| Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C | 1 |
| Fu, Z; Kong, L; Sun, XD; Xie, P; Yu, JM; Yue, JB; Zhao, HX | 1 |
| Heriot, A; Leong, T; Ngan, SY; Wang, ML | 1 |
| Buijsen, J; de Ruysscher, D; Janssen, MH; Lambin, P; Lammering, G; Ollers, MC; van den Bogaard, J; van Stiphout, RG | 1 |
| Alakus, H; Baldus, S; Bollschweiler, E; Brabender, J; Dietlein, M; Hölscher, AH; Metzger, R; Mönig, SP; Schmidt, M; Schneider, PM; Vallböhmer, D | 1 |
| Ball, DL; Binns, D; Ding, Z; Herschtal, A; Hicks, RJ; Hogg, A; Mac Manus, MP | 1 |
| Castellucci, P; Ceccarelli, C; Cola, B; Cuicchi, D; Di Fabio, F; Di Tullio, P; Fanti, S; Giaquinta, S; Iacopino, B; Lombardi, R; Martoni, AA; Pini, S; Pinto, C; Tardio, L | 1 |
| Aklilu, M; Blackstock, AW; Clark, P; Geisinger, KR; Isom, S; Levine, EA; Mishra, G; Monjazeb, AM; Riedlinger, G | 1 |
| Chang, AJ; Grigsby, PW; Richardson, S; Schwarz, JK | 1 |
| Akutsu, Y; Kono, T; Matsubara, H; Natsume, T; Ohira, G; Ota, T; Saito, H; Shuto, K; Toma, T; Uesato, M | 1 |
| Fury, MG; Jansen, JF; Koutcher, JA; Lee, NY; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Shukla-Dave, A; Stambuk, HE; Wang, Y | 1 |
| Banerjee, D; Bertino, JR; Blasberg, RG; Cai, S; de Stanchina, E; Kochetkov, T; Moroz, MA; Nair, J; Schwartz, GK; Serganova, I; Shamis, M; Wu, J | 1 |
| Albarghach, N; Corcos, L; Hatt, M; Le Rest, CC; Metges, JP; Pradier, O; Tixier, F; Visvikis, D | 1 |
| Chin, FT; Conti, PS; Fisher, GA; Kunz, P; Quon, A; Subbarayan, M; Zissen, MH | 1 |
| Huh, JW; Kim, HR; Kim, YJ; Lee, JH; Min, JJ | 1 |
| Ahn, SH; Han, KH; Kang, WJ; Kim, BK; Kim, DY; Kim, JK; Lee, DY; Lee, JD; Lee, KH; Park, JY; Seong, J | 1 |
| Akhurst, TJ; Chessin, DB; Guillem, JG; Larson, SM; Leibold, T; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Riedel, E; Saltz, LB; Shia, J; Weiser, MR; Wong, WD; Yeung, HW | 1 |
| Chezal, JM; Coudert, P; Daumar, P; Debiton, E; Decombat, C; Galmier, MJ; Madesclaire, M | 1 |
| Becker, K; Buck, AK; Ebert, MP; Herrmann, K; Krause, BJ; Langer, R; Lordick, F; Ott, K; Peschel, C; Schuster, T; Schwaiger, M; Siewert, JR; Wester, HJ; Wieder, HA; Wilhelm, D; zum Büschenfelde, CM | 1 |
| Cho, HJ; Han, KH; Kim, JW; Lee, IJ; Seong, J; Yoon, HI; Yun, M | 1 |
| Baghel, NS; Basu, S | 1 |
| Abel, U; Debus, J; Haag, GM; Haberkorn, U; Jäger, D; Lordick, F; Lorenzen, S; Münter, MW; Stange, A; von Gall, C; Weichert, W; Weitz, J | 1 |
| Cheng, EC; Ma, JB; Song, YP; Yu, JM; Zhang, XQ; Zhou, W | 1 |
| de Geus-Oei, LF; Gilles, R; Mulders, PF; Oyen, WJ | 1 |
| Helin, H; Karhumäki, L; Kauppi, JT; Kemppainen, J; Oksala, N; Räsänen, JV; Salo, JA; Sihvo, EI | 1 |
| Arrangoiz, R; Cooper, H; Farma, JM; Konski, A; Li, T; Nitzkorski, JR; Shanmugan, S; Sigurdson, ER; Yu, JQ | 1 |
| Choi, BI; Eo, JS; Goo, JM; Han, JK; Han, SW; Im, SA; Kim, DH; Kim, SH; Lee, ES; Paeng, JC; Willmann, JK | 1 |
| Chen, SJ; Deng, SM; Wang, ZX; Zhang, B | 1 |
| Cheuk, DK; Hossain, M; Krasin, MJ; Naik, M; Rodriguez-Galindo, C; Sabin, ND; Shulkin, BL; Wozniak, A | 1 |
| Collie-Duguid, ES; Law, AA; Smith, TA | 1 |
| Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A | 1 |
| Ceelen, W; De Bruyne, S; Ferdinande, L; Geboes, K; Laurent, S; Libbrecht, L; Mertens, J; Peeters, M; Smeets, P; Troisi, R; Van Damme, N; Van de Wiele, C | 1 |
| Barot, TC; Gulec, SA; Hall, M; Pennington, K; Schwartzentruber, D; Suthar, RR; Wheeler, J | 1 |
| Bydder, GM; Bydder, M; Cornell, M; Einck, J; Fanta, P; Hoh, CK; Lawson, JD; Liang, Y; Mell, LK; Mundt, AJ; Rose, BS; Saenz, C; Yashar, CM | 1 |
| Bernstine, H; Brenner, B; Goldberg, N; Gordon, N; Groshar, D; Idelevich, E; Kundel, Y; Morgenstern, S; Purim, O; Sulkes, A; Wasserberg, N | 1 |
| Abgral, R; Gouders, D; Keromnes, N; Le Roux, PY; Leleu, C; Mollon, D; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Valette, G | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Chen, W; D'Souza, WD; Feigenberg, S; Kim, G; Kligerman, S; Lu, M; Lu, W; Suntharalingam, M; Tan, S | 1 |
| Knox, JJ; Zhu, AX | 1 |
| Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D | 1 |
| Alessi, A; Avuzzi, B; Bampo, C; Bertarelli, G; Biondani, P; Bombardieri, E; Chiruzzi, C; Crippa, F; de Braud, F; Di Bartolomeo, M; Fantini, S; Mariani, L; Milione, M; Pietrantonio, F; Valvo, F | 1 |
| Bailão Aguilar, P; Buchpiguel, CA; Gama-Rodrigues, J; Habr-Gama, A; Lynn, P; Nahas, SC; Ono, CR; Perez, RO; Proscurshim, I; São Julião, GP | 1 |
| Duhamel, A; Huglo, D; Mariette, C; Mirabel, X; Petyt, G; Piessen, G | 1 |
| Bilic, S; Burris, HA; de Vries, EG; Gietema, JA; Goldbrunner, M; Infante, JR; Oldenhuis, CN; Parker, K; Scott, JW; Sharma, S; Yang, L | 1 |
| Ceelen, W; De Bruyne, S; Geboes, K; Goethals, I; Laurent, S; Mertens, J; Peeters, M; Smeets, P; Troisi, R; Van Damme, N; Van de Wiele, C | 1 |
| Lupinacci, RM; Menegaux, F; Simon, JM; Spano, JP | 1 |
| Choi, JY; Huh, SJ; Kim, BT; Lee, JE; Nam, H; Oh, D; Park, W | 1 |
| Bendell, JC; Burris, HA; Hoh, CK; Infante, JR; Kim, S; Reid, TR; Rosbrook, B; Tarazi, J | 1 |
| Benzon, EV; Brünner, N; Christensen, IJ; Engelmann, BE; Gerds, TA; Hansson, SH; Holländer, NH; Højgaard, L; Kjær, A; Kristensen, MH; Löfgren, J; Loft, A; Markova, E; Nielsen, HJ; Sloth, C | 1 |
| Aiba, T; Kato, K; Nagino, M; Nihashi, T; Tsuzuki, T; Uehara, K; Yatsuya, H; Yoshioka, Y | 1 |
| Christophi, C; Lau, LF; Lee, ST; Muralidharan, V; Scott, AM; Williams, DS | 1 |
| Hasegawa, M; Imai, Y; Kirita, T; Kuniyasu, H; Kurihara, M; Sasahira, T; Shimomura, H; Shirone, N; Tamaki, S; Yamakawa, N; Yamanaka, Y | 1 |
| Doki, Y; Fujiwara, Y; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Cai, XW; Feng, W; Fu, XL; Liu, Q; Yao, ZF; Yu, W; Zhang, Q; Zhang, YJ; Zhu, ZF | 1 |
| Chen, TT; Chiu, CF; Hsieh, CY; Hsieh, TC; Hua, CH; Lin, CC; Lin, CY; Sher, YP; Yang, TY; Yeh, SP | 1 |
| Alberini, JL; Bertrand, F; Champion, L; Fourme, E; Gontier, E; Lerebours, F; Wartski, M | 1 |
| Ajani, JA; Bhutani, MS; Blum, MA; Charalampakis, N; Elimova, E; Etchebehere, E; Hofstetter, W; Lee, JH; Macapinlac, HA; Maru, D; Planjery, V; Rogers, JE; Shimodaira, Y; Shiozaki, H; Skinner, HD; Wadhwa, R; Wang, X; Weston, BR | 1 |
| Bang, JI; Ha, S; Kang, SB; Kim, JS; Kim, SE; Lee, HS; Lee, HY; Lee, KW; Oh, HK | 1 |
| Baba, H; Baba, Y; Harada, K; Higashi, T; Ida, S; Imamura, Y; Ishimoto, T; Iwagami, S; Izumi, D; Kosumi, K; Miyamoto, Y; Miyata, T; Sakamoto, Y; Shiraishi, S; Taki, K; Tokunaga, R; Watanabe, M; Yamashita, Y; Yoshida, N | 1 |
| Chang, S; Kim, SJ; Koo, PJ; Kwak, JJ | 1 |
| Hara, K; Honjo, H; Kuwano, H; Miyazaki, T; Ozawa, D; Sakai, M; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T | 1 |
| Allen, JN; Blaszkowsky, LS; Drapek, LC; Hong, TS; Jee, KW; Lee, LK; Murphy, JE; Niemierko, A; Rose, BS; Wang, Y; Wo, JY | 1 |
| Deák, P; Fábián, G; Kahán, Z; Kovács, L; Mózes, P; Nagy, O; Pál, M; Reisz, Z; Rovó, L; Rusz, O; Szilágyi, É; Tiszlavicz, L; Tomisa, B; Varga, Z | 1 |
| Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH | 1 |
| Bassa, P; Capdevila, L; Garcia, JR; Pérez, C; Ramos, F; Valenti, V | 1 |
| Abe, O; Nakagawa, K; Yamashita, H | 1 |
| An, MS; Bae, KB; Baik, H; Hong, KH; Kim, KH; Lee, SM; Oh, MK; Seo, SH | 1 |
| Carter, BW; Goense, L; Ho, L; Hofstetter, WL; Lin, SH; Maru, DM; Meijer, GJ; van Hillegersberg, R; van Rossum, PSN; Xi, M | 1 |
| Katsuura, T; Kitajima, K; Kurahashi, Y; Odawara, S; Shinohara, H; Yamakado, K | 1 |
| Abel, U; Apostolidis, L; Berger, AK; Dietrich, M; Freitag, A; Giesel, F; Grüllich, C; Haag, GM; Haberkorn, U; Jäger, D; Lordick, F; Lücke, S; Ose, J; Stange, A; Trierweiler, C; von Gall, C; Weber, TF | 1 |
| Ishikura, S; Kondo, T; Miyakawa, A; Murai, T; Ozawa, Y; Shibamoto, Y; Sugie, C; Yanagi, T | 1 |
| Abgral, R; Amrane, K; le Pennec, R; Metges, JP; Schick, U | 1 |
| Bekaii-Saab, T; Boffa, DJ; Frankel, WL; Fruth, B; Goodman, KA; Hall, NC; Ilson, DH; Janjigian, YY; Meyerhardt, JA; Meyers, MO; Mitchell, K; Niedzwiecki, D; Noonan, A; O'Reilly, EM; Ou, FS; Thurmes, PJ; Twohy, E; Venook, AP | 1 |
3 review(s) available for fluorodeoxyglucose f18 and fluorouracil
| Article | Year |
|---|---|
[Positron emitters for the study of tumor metabolism].
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasms; Tomography, Emission-Computed | 1989 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[A case of long-term survival after resection for postoperative solitary adrenal metastasis from esophageal adenocarcinoma].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Male; Organoplatinum Compounds; Positron-Emission Tomography | 2010 |
28 trial(s) available for fluorodeoxyglucose f18 and fluorouracil
| Article | Year |
|---|---|
Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.
Topics: Adenocarcinoma; Aged; Animals; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1999 |
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours.
Topics: Adenosylmethionine Decarboxylase; Adult; Aged; Agranulocytosis; Amidines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Indans; Male; Middle Aged; Neoplasms; Polyamines; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 2000 |
FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Vinblastine | 2002 |
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
PET-FDG as predictor of therapy response in patients with colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Radiopharmaceuticals; Risk Assessment; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Kinetics; Leucovorin; Organoplatinum Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Misonidazole; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome | 2005 |
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Treatment Outcome | 2008 |
Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2010 |
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Monitoring; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Neoadjuvant Therapy; Neutrons; Pancreatectomy; Pancreatic Neoplasms; Photons; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Treatment Outcome | 2010 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gastrectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2010 |
Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Imaging, Three-Dimensional; Leucovorin; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Organoplatinum Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Camptothecin; Chemoradiotherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemoradiotherapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Inguinal Canal; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Bevacizumab; Camptothecin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gastrointestinal Neoplasms; Humans; Imidazoles; Indazoles; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Withholding Treatment | 2014 |
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2014 |
Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Outcome Assessment, Health Care; Oxaliplatin; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Taxoids; Tomography, X-Ray Computed | 2015 |
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Topics: Adult; Aged; Camptothecin; Cetuximab; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Prospective Studies | 2018 |
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Oxaliplatin; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Young Adult | 2021 |
99 other study(ies) available for fluorodeoxyglucose f18 and fluorouracil
| Article | Year |
|---|---|
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colonic Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interleukin-2; Liver Neoplasms; Recombinant Proteins; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1992 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxyglucose; Edema; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Tomography, Emission-Computed | 1993 |
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Body Weight; Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Recombinant Proteins; Tomography, Emission-Computed | 1996 |
The direct calculation of parametric images from dynamic PET data using maximum-likelihood iterative reconstruction.
Topics: Algorithms; Biophysical Phenomena; Biophysics; Carbon Dioxide; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Models, Theoretical; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Injections, Intra-Arterial; Injections, Intravenous; Liver Neoplasms; Oxygen Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Water | 1998 |
18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Topics: Aged; Antidotes; Antimetabolites, Antineoplastic; Carcinoma; Colorectal Neoplasms; Drug Interactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Long-term follow-up and therapeutic control of a hepatic metastatic acinar cell carcinoma of the pancreas using FDG PET].
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Ultrasonography | 1998 |
FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 1999 |
Metabolites of 2'-fluoro-2'-deoxy-D-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Extracts; Fibrosarcoma; Fluorodeoxyglucose F18; Fluorouracil; Glucose-6-Phosphate Isomerase; Hexokinase; Isomerism; Isotopes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Rhamnose; Treatment Outcome; Tumor Cells, Cultured | 2000 |
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Neoadjuvant Therapy; Neoplasm Staging; Pilot Projects; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Evaluation by FDG-PET of arterial infusion chemotherapy for unresectable metastatic liver tumor].
Topics: Aged; Antimetabolites, Antineoplastic; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Rectal Neoplasms; Tomography, Emission-Computed | 2000 |
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Long-term complete remission of oral cancer after anti-neoplastic chemotherapy as single treatment modality: role of local chemotherapy.
Topics: Aged; Antineoplastic Agents; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms | 2002 |
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured | 2002 |
3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Topics: Adenosine Triphosphate; Animals; Dideoxynucleosides; Drug Monitoring; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasms; Neoplasms, Experimental; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous | 2003 |
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Tomography, Emission-Computed | 2004 |
Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Colectomy; Fluorodeoxyglucose F18; Fluorouracil; Humans; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Remission Induction; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Catheter Ablation; Catheters, Indwelling; Colonic Neoplasms; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; Tomography, Spiral Computed; Treatment Outcome | 2005 |
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prospective Studies; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
Thyroid metastasis from colorectal cancer: role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Rectal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2005 |
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Radiotherapy; Rectal Neoplasms | 2005 |
Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Glucose Transporter Type 1; Hexokinase; Humans; Radiopharmaceuticals; RNA, Messenger; Tritium | 2006 |
FDG-PET in colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Monitoring chemotherapeutic response in RIF-1 tumors by single-quantum and triple-quantum-filtered (23)Na MRI, (1)H diffusion-weighted MRI and PET imaging.
Topics: Animals; Antineoplastic Agents; Diffusion Magnetic Resonance Imaging; Drug Monitoring; Fibrosarcoma; Fluorodeoxyglucose F18; Fluorouracil; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C3H; Radiopharmaceuticals; Sodium; Temperature; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Tumor Cells, Cultured; Water | 2007 |
[18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Flow Cytometry; Fluorodeoxyglucose F18; Fluorouracil; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tumor Cells, Cultured | 2007 |
Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro.
Topics: Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2007 |
The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Clinical Trials, Phase II as Topic; ErbB Receptors; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2007 |
Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biological Transport; Camptothecin; Cell Line, Tumor; Cell Survival; Cetuximab; Colorectal Neoplasms; Drug Interactions; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Hexokinase; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Radiopharmaceuticals | 2008 |
Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?
Topics: Antimetabolites, Antineoplastic; Cell Hypoxia; Combined Modality Therapy; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2008 |
[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Doxorubicin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Paclitaxel; Thymidine; Thymidine Kinase | 2008 |
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Liver Neoplasms; Microspheres; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiation Dosage; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Statistics, Nonparametric | 2009 |
Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Deoxycytidine; Fascia; Fasciotomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Software; Survival Rate; Tomography, X-Ray Computed | 2008 |
Arterial infusion chemotherapy in patient with repeated recurrent tumor of cecal cancer: report of a case.
Topics: Antimetabolites, Antineoplastic; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leucovorin; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Positron-Emission Tomography | 2009 |
Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls.
Topics: Aged; Aged, 80 and over; Algorithms; Antimetabolites, Antineoplastic; Combined Modality Therapy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Tomography, X-Ray Computed | 2009 |
The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2009 |
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; ROC Curve; Sample Size; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy, Adjuvant; Rectal Neoplasms; Retrospective Studies; Treatment Outcome | 2011 |
Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Irradiation; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 2011 |
Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Contrast Media; Deoxycytidine; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Platinum Compounds; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Treatment Outcome | 2010 |
Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Femur Head; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Intestines; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder; Uterine Cervical Neoplasms | 2012 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Choline; Cisplatin; Contrast Media; Diagnostic Imaging; Extracellular Space; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Gadolinium DTPA; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; HCT116 Cells; Humans; Immunoblotting; Ki-67 Antigen; Methotrexate; Mice; Mice, Nude; Organophosphates; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Xenograft Model Antitumor Assays | 2011 |
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2011 |
18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Area Under Curve; Bevacizumab; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Hepatocellular; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Research Design; Treatment Outcome | 2011 |
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2011 |
Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Liberation; Drug Stability; Fluorodeoxyglucose F18; Fluorouracil; Half-Life; Humans; Prodrugs; Structure-Activity Relationship | 2011 |
Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cisplatin; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Glucose; Humans; Immunoenzyme Techniques; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Rate | 2011 |
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Treatment Outcome | 2012 |
Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Germany; Humans; Multicenter Studies as Topic; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Taxoids; Treatment Outcome | 2011 |
Linear correlation between patient survival and decreased percentage of tumor [(18)F]fluorodeoxyglucose uptake for late-course accelerated hyperfractionated radiotherapy for esophageal cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; China; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Linear Models; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Taxoids; Tomography, X-Ray Computed | 2012 |
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed | 2012 |
Early evaluation for treatment efficacy of 5-fluorouracil and hyperthermia on HCT-116 colon cancer cells by fluorine-18-fluorodeoxyglucose uptake.
Topics: Apoptosis; Cell Proliferation; Colonic Neoplasms; Fever; Fluorodeoxyglucose F18; Fluorouracil; HCT116 Cells; Humans; Microscopy, Electron, Transmission | 2012 |
Influence of resistance to 5-fluorouracil and tomudex on [18F]‑FDG incorporation, glucose transport and hexokinase activity.
Topics: 3-O-Methylglucose; Antimetabolites, Antineoplastic; Biological Transport; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Hexokinase; Humans; Quinazolines; Radiopharmaceuticals; Thiophenes | 2012 |
Role of positron emission tomography-computed tomography in the management of anal cancer.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cisplatin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Multimodal Imaging; Organ Sparing Treatments; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spatio-Temporal Analysis; Tomography, X-Ray Computed | 2013 |
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Biopsy; CA-125 Antigen; Capecitabine; Carcinoembryonic Antigen; Carrier Proteins; CDX2 Transcription Factor; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cytokines; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Glycoproteins; Hepatectomy; Homeodomain Proteins; Humans; Immunohistochemistry; Keratin-20; Keratins; Liver; Liver Neoplasms; Lymph Node Excision; Magnetic Resonance Imaging; Membrane Transport Proteins; Phenotype; Portal Vein; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 2012 |
[Esophageal cancer: outcome according to therapeutic strategy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Data Interpretation, Statistical; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2013 |
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Demography; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Receptors, TNF-Related Apoptosis-Inducing Ligand | 2014 |
Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mitomycin; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
MRI and FDG-PET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaloacetates; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; ROC Curve; Treatment Outcome | 2014 |
Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
[18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2015 |
Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals | 2015 |
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiography; Survival Rate | 2015 |
Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Imaging, Three-Dimensional; Leucovorin; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Taxoids; Treatment Outcome | 2016 |
Changes in Total Lesion Glycolysis Evaluated by Repeated F-18 FDG PET/CT as Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Preoperative Chemoradiotherapy.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography for Predicting the Pathological Response of Neoadjuvant Chemoradiotherapy for T4 Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Taxoids; Treatment Outcome | 2015 |
Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
Topics: Adult; Aged; Antineoplastic Agents; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cohort Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Linear Models; Male; Middle Aged; Mitomycin; Neutropenia; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2016 |
The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA Damage; DNA Repair; Docetaxel; Down-Regulation; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck; Taxoids; Up-Regulation | 2017 |
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2016 |
18F-FDG PET/CT in the Staging and Management of Breast Cancer: Value in Disease Outcome and Planning Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Axilla; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Letrozole; Lymph Node Excision; Lymph Nodes; Mastectomy; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Ribs; Taxoids; Triazoles; Zoledronic Acid | 2017 |
Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Organoplatinum Compounds; Positron-Emission Tomography | 2017 |
Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Colectomy; Colonic Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2018 |
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Nomograms; Oxaliplatin; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Radiotherapy Dosage; Risk Assessment; Sex Factors; Survival Rate | 2018 |
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Infusions, Intravenous; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2018 |
Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2020 |
Complete Metabolic Response Assessed by FDG PET/CT to FOLFOXIRI-Bevacizumab in First-Line Treatment of BRAFV600E Mutated Metastatic Colorectal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cetuximab; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Middle Aged; Mutation; Neoplasm Metastasis; Organoplatinum Compounds; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins B-raf; Treatment Outcome | 2020 |